z-logo
open-access-imgOpen Access
Iron load
Author(s) -
Filippo Cassarà,
Aurelio Maggio
Publication year - 2013
Publication title -
thalassemia reports
Language(s) - English
Resource type - Journals
eISSN - 2039-4365
pISSN - 2039-4357
DOI - 10.4081/thal.2013.s1.e5
Subject(s) - hepcidin , medicine , thalassemia , hemochromatosis , deferoxamine , splenectomy , deferasirox , anemia , hereditary hemochromatosis , liver damage , intensive care medicine , physiology , spleen
Recent research addressed the main role of hepcidin in the regulation of iron metabolism. However, while this mechanism could be relevant in causing iron load in Thalassemia Intermedia and Sickle-Cell Anemia, its role in Thalassemia Major (TM) is marginal. This is mainly due to the high impact of transfusional requirement into the severe increase of body iron. Moreover, the damage of iron load may be worsened by infections, as HCV hepatitis, or liver and endocrinological damage. One of the most relevant associations was found between splenectomy and increase of risk for mortality due,probably, to more severe iron load. These issues suggest as morbidity and mortality of this group of patients they do not depend only by our ability in controlling heart damage but even in preventing or treating particular infections and complications. This finding is supported by the impairment of survival curves in patients with complications different from heart damage. However, because, during recent years different direct and indirect methods to detect iron overload in patients affected by secondary hemochromatosis have been implemented, our ability to maintain under control iron load is significantly improved. Anyway, the future in iron load management remains to be able to have an iron load map of our body for targeting chelation and other medical treatment according to the single organ damage

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here